Home›Companies›Biotech & Pharma›Sialia Therapeutics

Sialia Therapeutics, Inc.

No website or LinkedIn page we could confirm. Why?
Updated Nov 9, 2026·Latest SEC filing Sep 29, 2026·Suggest an edit

About Sialia Therapeutics

Sialia Therapeutics is a private company based in Irvine, California, incorporated in 2026 in Delaware. It has reported $1,500,000 raised in one offering on Form D since September 2026. Its chief executive is Litain Yeh.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 2, 2026Sep 29, 2026$1,500,000fully sold1$1.5MOptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Sialia Therapeutics's Form D filed Sep 29, 2026.

LY
Litain Yeh
CEO and director

Sources

  1. SECSialia Therapeutics, Inc. filing history